Trial Profile
Examination of liver function improvement effect by administering a Ipragliflozin.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Oct 2021
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Liver disorders; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Oct 2021 Status changed from recruiting to completed.
- 04 Feb 2015 New trial record